Cytochrome P450 2D6 polymorphism and its impact on decision-making in psychopharmacotherapy: finding the right way in an ultrarapid metabolizing patient.

Source: Journal of Clinical Psychiatry

Paulzen M, Tauber SC, Kirner-Veselinovic A, et al.  | |  

View the original article

Login or register to help identify topics from this page.

This page may contain content contributed by CPNP members or aggregated from other online sources. This content is provided as an unmoderated service to members for civil discussion and collaboration. Any opinions, conclusions, or recommendations are those of the author. If you come across any abuse or violation of the terms of use, please report the abuse.